Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
Status:
Terminated
Trial end date:
2016-02-10
Target enrollment:
Participant gender:
Summary
This clinical trial studies capecitabine and celecoxib in treating patients with solid
malignancies that are metastatic or cannot be removed by surgery. Drugs used in chemotherapy,
such as capecitabine, work in different ways to stop the growth of tumor cells, either by
killing the cells or by stopping them from dividing. Celecoxib may stop the growth of tumor
cells by blocking some of the enzymes needed for cell growth. Giving capecitabine and
celecoxib together may be an effective treatment for solid malignancies.